Tinlo ® Tablet 150 mg
(Erlotinib 150 mg)
GENERIC NAME: Erlotinib 150 mg
THERAPEUTIC CLASS: Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor
INDICATIONS & DOSAGE:
- Non-Small Cell Lung Cancer
- Metastatic Pancreatic Cancer
STORAGE: Store below 30°C. Protect from light and moisture.
PACK SIZE: 3X10’s
DOSAGE & ADMINISTRATION:
- Non-Small Cell Lung Cancer: One tablet of Erlotinib 150 mg each day.
- Metastatic Pancreatic Cancer: One tablet of Erlotinib 100 mg each day in combination with gemcitabine tablet.
